Hong Kong-based investment management firm Adamas Asset Management recently announced the completion of a $15-million convertible bond investment into biopharma firm Aptorum Group through its third fund, Adamas Ping An Opportunities Fund (Adamas Ping An).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
